BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12088268)

  • 1. Tea tree oil reduces histamine-induced oedema in murine ears.
    Brand C; Townley SL; Finlay-Jones JJ; Hart PH
    Inflamm Res; 2002 Jun; 51(6):283-9. PubMed ID: 12088268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response.
    Brand C; Grimbaldeston MA; Gamble JR; Drew J; Finlay-Jones JJ; Hart PH
    Inflamm Res; 2002 May; 51(5):236-44. PubMed ID: 12056511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol.
    Greay SJ; Ireland DJ; Kissick HT; Levy A; Beilharz MW; Riley TV; Carson CF
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):877-88. PubMed ID: 19680653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of wheal and flare by tea tree oil: complementary human and rodent studies.
    Khalil Z; Pearce AL; Satkunanathan N; Storer E; Finlay-Jones JJ; Hart PH
    J Invest Dermatol; 2004 Oct; 123(4):683-90. PubMed ID: 15373773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tea tree oil reduces histamine-induced skin inflammation.
    Koh KJ; Pearce AL; Marshman G; Finlay-Jones JJ; Hart PH
    Br J Dermatol; 2002 Dec; 147(6):1212-7. PubMed ID: 12452873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topically applied Melaleuca alternifolia (tea tree) oil causes direct anti-cancer cytotoxicity in subcutaneous tumour bearing mice.
    Ireland DJ; Greay SJ; Hooper CM; Kissick HT; Filion P; Riley TV; Beilharz MW
    J Dermatol Sci; 2012 Aug; 67(2):120-9. PubMed ID: 22727730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol.
    Walton SF; McKinnon M; Pizzutto S; Dougall A; Williams E; Currie BJ
    Arch Dermatol; 2004 May; 140(5):563-6. PubMed ID: 15148100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ricinoleic acid in acute and subchronic experimental models of inflammation.
    Vieira C; Evangelista S; Cirillo R; Lippi A; Maggi CA; Manzini S
    Mediators Inflamm; 2000; 9(5):223-8. PubMed ID: 11200362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis.
    Ninomiya K; Maruyama N; Inoue S; Ishibashi H; Takizawa T; Oshima H; Abe S
    Biol Pharm Bull; 2012; 35(6):861-5. PubMed ID: 22687476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of nickel-induced contact hypersensitivity reactions by topical tea tree oil in humans.
    Pearce AL; Finlay-Jones JJ; Hart PH
    Inflamm Res; 2005 Jan; 54(1):22-30. PubMed ID: 15723201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human skin penetration of the major components of Australian tea tree oil applied in its pure form and as a 20% solution in vitro.
    Cross SE; Russell M; Southwell I; Roberts MS
    Eur J Pharm Biopharm; 2008 May; 69(1):214-22. PubMed ID: 17983738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-oedematous action of some H1-receptor antagonists.
    Blazsó G; Gábor M
    Agents Actions; 1994 Aug; 42(1-2):13-8. PubMed ID: 7531386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical use of tea tree oil reduces the dermal absorption of benzoic acid and methiocarb.
    Nielsen JB; Nielsen F
    Arch Dermatol Res; 2006 Mar; 297(9):395-402. PubMed ID: 16315066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.
    Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G
    BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.
    Greay SJ; Ireland DJ; Kissick HT; Heenan PJ; Carson CF; Riley TV; Beilharz MW
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1095-102. PubMed ID: 20577741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tea tree oil: a systematic review of randomized clinical trials.
    Ernst E; Huntley A
    Forsch Komplementarmed Klass Naturheilkd; 2000 Feb; 7(1):17-20. PubMed ID: 10800248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by actinomycin D of neurogenic mouse ear oedema.
    Inoue H; Nagata N; Koshihara Y
    Inflamm Res; 1995 Mar; 44(3):125-30. PubMed ID: 7552577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of applications of tea tree oil in dermatology.
    Pazyar N; Yaghoobi R; Bagherani N; Kazerouni A
    Int J Dermatol; 2013 Jul; 52(7):784-90. PubMed ID: 22998411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cidal activity of tea tree oil and terpinen-4-ol against clinical bacterial skin isolates and human fibroblast cells.
    Loughlin R; Gilmore BF; McCarron PA; Tunney MM
    Lett Appl Microbiol; 2008 Apr; 46(4):428-33. PubMed ID: 18298453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model.
    Baldissera MD; Da Silva AS; Oliveira CB; Santos RC; Vaucher RA; Raffin RP; Gomes P; Dambros MG; Miletti LC; Boligon AA; Athayde ML; Monteiro SG
    Exp Parasitol; 2014 Jun; 141():21-7. PubMed ID: 24657576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.